Salt Hill Charity
The Charity's objects are the advancement of health for public benefit, in particular but without limitation, by promoting medical research and innovation through supporting scientific and technological discoveries to transition to therapeutics assess assessment and ultimately to the benefit of patients with current unmet needs.
Objects
THE ADVANCEMENT OF HEALTH FOR PUBLIC BENEFIT, IN PARTICULAR BUT WITHOUT LIMITATION, BY PROMOTING MEDICAL RESEARCH AND INNOVATION THROUGH SUPPORTING SCIENTIFIC AND TECHNOLOGICAL DISCOVERIES TO TRANSITION TO THERAPEUTIC ASSESSMENT AND ULTIMATELY TO THE BENEFIT OF PATIENTS WITH CURRENT UNMET NEEDS.
Policies the charity declares
- Conflicting interests
- Investment
- Risk management
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2022
- Employees paid over £60,000: 4 (£60,001–£70,000: 1; £100,001–£110,000: 1; £140,001–£150,000: 2)
Self-declared on the annual return for the financial year ending 31/12/2021
- Employees paid over £60,000: 4 (£60,001–£70,000: 1; £90,001–£100,000: 1; £100,001–£110,000: 1; £200,001–£250,000: 1)
Annual return filing dates (Charity Commission record)
Of its last 5 annual returns with a recorded received date, 5 were received after the due date: year ending 31/12/2025 (received 03/11/2026, 3 days after the 31/10/2026 due date); year ending 31/12/2024 (received 24/12/2025, 54 days after the 31/10/2025 due date); year ending 31/12/2023 (received 14/12/2024, 44 days after the 31/10/2024 due date); year ending 31/12/2022 (received 18/07/2024, 261 days after the 31/10/2023 due date); year ending 31/12/2021 (received 05/06/2023, 217 days after the 31/10/2022 due date).
Structured financials (annual return, FY ending 31/12/2021)
Trustees
- DR ROSS BRECKENRIDGE
- PROFESSOR JOHN FRANCIS MARTIN
- ROBERT UNWIN
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £0 | £603k |
| 31/12/2024 | £0 | £374k |
| 31/12/2023 | £0 | £928k |
| 31/12/2022 | £155k | £1.1m |
| 31/12/2021 | £4.9m | £4.3m |